HOME >> MEDICINE >> NEWS
Four new us patents granted to Acrux for transdermal drug delivery

Acrux Limited (ASX: ACR), the Australian pharmaceutical company that specialises in products delivering therapeutic drugs through the skin, today announced that it has been granted four more US patents relating to its transdermal drug delivery technology. The four US patents provide additional protection for systemic delivery of drugs in specific therapeutic areas, namely analgesics (US patent number 6,916,486), hormones (6,923,983), anti-Parkinson's agents (6,929,801) and anti-emetics (6,916,487). These are "continuation in part" patents, related to Acrux's US patent number 6,818,226.

The new patents, which expire in February 2017, further extend the proprietary nature of Acrux's transdermal drug delivery technology for a number of products in the current pipeline. They provide protection for transdermal drug delivery systems, in the specific therapy areas, that consist of an effective amount of physiologically active agent (e.g. a therapeutic drug), a dermal penetration enhancer, which is a safe skin-tolerant ester sunscreen, and a volatile liquid. Acrux now has six patents granted in the USA.

Acrux CEO and Managing Director, Dr Igor Gonda said: "These new US patents provide additional protection for our products in our core areas of interest. Our patenting activity is at the heart of our business strategy to develop and commercialise patient-preferred patent-protected healthcare products for valuable global markets."


'"/>

Contact: Igor Gonda
61-383-790-100
Research Australia
26-Sep-2005


Page: 1

Related medicine news :

1. REVLIMID(R) granted approval by FDA for treatment of multiple myeloma
2. Acrux granted first grant in Europe, triggering payment from Lilly
3. GroPep news: Key psoriasis patent granted in Japan and new asthma patent filed for GroPep drug
4. Acrux completes enrollment in key phase 2 trial
5. Acrux and Oreganon further expand their collaboration
6. Acrux patent portfolio advances in USA
7. Acrux acquires rights to commercialise worlds first contraceptive spray
8. Acrux reports progress in development of Testosterone MD-Lotion(R) for men
9. DAYTRANA (methylphenidate transdermal system) significant reduces ADHD symptoms
10. Shires DAYTRANA(TM) transdermal patch approved by FDA for treatment of ADHD
11. Positive study results for methylphenidate transdermal system

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/16/2018)... ... 2018 , ... The months of training are over. The race has come and gone. It ... they were put through the wringer after the big event. Read on for something healthy ... Motion on how to treat the body and mind after a long run: , 1. ...
(Date:10/13/2018)... ... October 12, 2018 , ... Convoy of Hope is positioned ... and a disaster service team to the devastated Florida Panhandle to begin response operations ... help Convoy’s disaster response teams and provide supplies to those affected by the storm. ...
(Date:10/11/2018)... ... 11, 2018 , ... Cognosante, a leader in health information ... in contact center monitoring and quality assurance. , Inspired by Jackie ... alternative work environments and flexible schedules, providing remote job opportunities to an under-employed ...
(Date:10/11/2018)... (PRWEB) , ... October 11, 2018 , ... ... of Ambulatory medical clinic of all sizes and specialties. PrognoCIS , their ... based care for their patients. , Greater Houston Healthconnect (GHH), the region’s health ...
(Date:10/6/2018)... ... October 06, 2018 , ... Jose Rodriguez- ... Miami. , Haute Beauty, well known for their exclusivity, and luxurious lifestyle ... surgeon and our newest addition to the Haute Living network. , Haute ...
Breaking Medicine News(10 mins):
(Date:10/11/2018)... ... 2018 , ... In the last four months it has also obtained grant ... of six more in USA, China and Japan from three other patent families covering ... security products. , The patents assigned from QinetiQ include US 7113092, titled “Ferromagnetic Object ...
(Date:10/6/2018)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 06, 2018 , ... ... weight after surgery or an injury. Carol Rowsemitt, PhD, RN, FNP-C, a San ... have trouble losing weight. She understands this better than most dietitians. , Rowsemitt specializes ...
(Date:10/5/2018)... ... ... Shango Las Vegas dispensary will team with Ink Ribbon Foundation breast cancer charity ... to raise funds for the Las Vegas nonprofit group that helps women pay for ... After being spurned by three national and a few local charities devoted to helping ...
Breaking Medicine Technology:
Cached News: